Read news on glp-1s with our app.
Read more in the app
Eli Lilly CEO Dave Ricks says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
More Than 1 Million Americans Are Taking Ozempic and Other GLP-1s Without an Approved Reason. Is That Actually a Problem?
Nearly 1 in 6 Kids on GLP-1s Developed This Problem Within a Year
GLP-1s are being linked to fewer serious infections, including TB
Launch HN: RonanRX (YC S26) – Personalized Peptides and GLP-1s
GLP-1s May Spur Next Wave in Youth Social Media Harm Claims
Morgan Health CEO: Tech, GLP-1s, Labor Driving up Costs
Samsung is testing Galaxy Watch 8 to prevent muscle loss on GLP-1s like Ozempic
The Biochemical Beauty of Retatrutide: How GLP-1s Work
GLP-1s and hair loss: Study finds a new link
Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists
